These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 15352904

  • 1. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 3. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 4. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 5. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F.
    Digestion; 2007 Nov; 76(2):116-29. PubMed ID: 18239403
    [Abstract] [Full Text] [Related]

  • 6. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 7. How effective are the usual treatments for Crohn's disease?
    Bebb JR, Scott BB.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):151-9. PubMed ID: 15233694
    [Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 9. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C, Scribano ML.
    Ital J Gastroenterol Hepatol; 1999 Jul 15; 31(6):515-8. PubMed ID: 10575572
    [Abstract] [Full Text] [Related]

  • 10. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ, Feagan BG, Lichtenstein GR.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):987-1003. PubMed ID: 17877506
    [Abstract] [Full Text] [Related]

  • 11. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
    Sandborn WJ, Hanauer SB.
    Am J Gastroenterol; 2002 Dec 01; 97(12):2962-72. PubMed ID: 12492177
    [Abstract] [Full Text] [Related]

  • 12. Maintenance of remission in Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Felley C, Burnand B, Vader JP, Michetti P, Froehlich F.
    Digestion; 2005 Dec 01; 71(1):41-8. PubMed ID: 15711049
    [Abstract] [Full Text] [Related]

  • 13. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Colombel JF, Lémann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, Notteghem B, Mary JY.
    Am J Gastroenterol; 1999 Mar 01; 94(3):674-8. PubMed ID: 10086650
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 01; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

  • 15. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G.
    Clin Gastroenterol Hepatol; 2003 Mar 01; 1(2):122-8. PubMed ID: 15017504
    [Abstract] [Full Text] [Related]

  • 16. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 01; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun 01; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 19. Corticosteroid-sparing treatments in patients with Crohn's disease.
    Plevy SE.
    Am J Gastroenterol; 2002 Jul 01; 97(7):1607-17. PubMed ID: 12135008
    [Abstract] [Full Text] [Related]

  • 20. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May 01; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.